A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial

Bibliographic Details
Title: A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial
Authors: Soo, R.A. a, Vervita, K. b, Früh, M. c, d, Cho, B.C. e, Majem, M. f, g, Rodriguez Abreu, D. h, g, Ribi, K. i, Callejo, A. g, j, Moran, T. g, k, Domine Gomez, M. l, g, Provencio, M. g, m, Addeo, A. n, Han, J.Y. o, Ortega Granados, A.L. p, g, Reck, M. q, Blasco, A. r, g, Garcia Campelo, R. s, g, Sala González, M.A. t, g, Britschgi, C. u, Roschitzki-Voser, H. i, Ruepp, B. i, Gasca-Ruchti, A. i, Haberecker, M. v, Dafni, U. d, w, Peters, S. x, Stahel, R.A. i, ⁎
Source: In Lung Cancer April 2025 202
Database: ScienceDirect
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://www.doi.org/10.1016/j.lungcan.2025.108454?
    Name: ScienceDirect (all content)-s8985755
    Category: fullText
    Text: View record from ScienceDirect
    MouseOverText: View record from ScienceDirect
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edselp&genre=article&issn=01695002&ISBN=&volume=202&issue=&date=20250401&spage=&pages=&title=Lung Cancer&atitle=A%20randomised%20non-comparative%20phase%20II%20study%20of%20atezolizumab%2C%20bevacizumab%20and%20chemotherapy%20in%20EGFR-mutant%20NSCLC%20with%20acquired%20resistance%20%E2%80%93%20The%20ETOP%2015-19%20ABC-lung%20trial&aulast=Soo%2C%20R.A.&id=DOI:10.1016/j.lungcan.2025.108454
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edselp
DbLabel: ScienceDirect
An: S0169500225000753
RelevancyScore: 1182
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1181.92016601563
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Soo%2C+R%2EA%2E%22">Soo, R.A.</searchLink> <superscript>a</superscript><br /><searchLink fieldCode="AR" term="%22Vervita%2C+K%2E%22">Vervita, K.</searchLink> <superscript>b</superscript><br /><searchLink fieldCode="AR" term="%22Früh%2C+M%2E%22">Früh, M.</searchLink> <superscript>c, d</superscript><br /><searchLink fieldCode="AR" term="%22Cho%2C+B%2EC%2E%22">Cho, B.C.</searchLink> <superscript>e</superscript><br /><searchLink fieldCode="AR" term="%22Majem%2C+M%2E%22">Majem, M.</searchLink> <superscript>f, g</superscript><br /><searchLink fieldCode="AR" term="%22Rodriguez+Abreu%2C+D%2E%22">Rodriguez Abreu, D.</searchLink> <superscript>h, g</superscript><br /><searchLink fieldCode="AR" term="%22Ribi%2C+K%2E%22">Ribi, K.</searchLink> <superscript>i</superscript><br /><searchLink fieldCode="AR" term="%22Callejo%2C+A%2E%22">Callejo, A.</searchLink> <superscript>g, j</superscript><br /><searchLink fieldCode="AR" term="%22Moran%2C+T%2E%22">Moran, T.</searchLink> <superscript>g, k</superscript><br /><searchLink fieldCode="AR" term="%22Domine+Gomez%2C+M%2E%22">Domine Gomez, M.</searchLink> <superscript>l, g</superscript><br /><searchLink fieldCode="AR" term="%22Provencio%2C+M%2E%22">Provencio, M.</searchLink> <superscript>g, m</superscript><br /><searchLink fieldCode="AR" term="%22Addeo%2C+A%2E%22">Addeo, A.</searchLink> <superscript>n</superscript><br /><searchLink fieldCode="AR" term="%22Han%2C+J%2EY%2E%22">Han, J.Y.</searchLink> <superscript>o</superscript><br /><searchLink fieldCode="AR" term="%22Ortega+Granados%2C+A%2EL%2E%22">Ortega Granados, A.L.</searchLink> <superscript>p, g</superscript><br /><searchLink fieldCode="AR" term="%22Reck%2C+M%2E%22">Reck, M.</searchLink> <superscript>q</superscript><br /><searchLink fieldCode="AR" term="%22Blasco%2C+A%2E%22">Blasco, A.</searchLink> <superscript>r, g</superscript><br /><searchLink fieldCode="AR" term="%22Garcia+Campelo%2C+R%2E%22">Garcia Campelo, R.</searchLink> <superscript>s, g</superscript><br /><searchLink fieldCode="AR" term="%22Sala+González%2C+M%2EA%2E%22">Sala González, M.A.</searchLink> <superscript>t, g</superscript><br /><searchLink fieldCode="AR" term="%22Britschgi%2C+C%2E%22">Britschgi, C.</searchLink> <superscript>u</superscript><br /><searchLink fieldCode="AR" term="%22Roschitzki-Voser%2C+H%2E%22">Roschitzki-Voser, H.</searchLink> <superscript>i</superscript><br /><searchLink fieldCode="AR" term="%22Ruepp%2C+B%2E%22">Ruepp, B.</searchLink> <superscript>i</superscript><br /><searchLink fieldCode="AR" term="%22Gasca-Ruchti%2C+A%2E%22">Gasca-Ruchti, A.</searchLink> <superscript>i</superscript><br /><searchLink fieldCode="AR" term="%22Haberecker%2C+M%2E%22">Haberecker, M.</searchLink> <superscript>v</superscript><br /><searchLink fieldCode="AR" term="%22Dafni%2C+U%2E%22">Dafni, U.</searchLink> <superscript>d, w</superscript><br /><searchLink fieldCode="AR" term="%22Peters%2C+S%2E%22">Peters, S.</searchLink> <superscript>x</superscript><br /><searchLink fieldCode="AR" term="%22Stahel%2C+R%2EA%2E%22">Stahel, R.A.</searchLink> <superscript>i, ⁎</superscript>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: In <searchLink fieldCode="JN" term="%22Lung+Cancer%22">Lung Cancer</searchLink> April 2025 202
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edselp&AN=S0169500225000753
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2025.108454
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance – The ETOP 15-19 ABC-lung trial
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Soo, R.A.
      – PersonEntity:
          Name:
            NameFull: Vervita, K.
      – PersonEntity:
          Name:
            NameFull: Früh, M.
      – PersonEntity:
          Name:
            NameFull: Cho, B.C.
      – PersonEntity:
          Name:
            NameFull: Majem, M.
      – PersonEntity:
          Name:
            NameFull: Rodriguez Abreu, D.
      – PersonEntity:
          Name:
            NameFull: Ribi, K.
      – PersonEntity:
          Name:
            NameFull: Callejo, A.
      – PersonEntity:
          Name:
            NameFull: Moran, T.
      – PersonEntity:
          Name:
            NameFull: Domine Gomez, M.
      – PersonEntity:
          Name:
            NameFull: Provencio, M.
      – PersonEntity:
          Name:
            NameFull: Addeo, A.
      – PersonEntity:
          Name:
            NameFull: Han, J.Y.
      – PersonEntity:
          Name:
            NameFull: Ortega Granados, A.L.
      – PersonEntity:
          Name:
            NameFull: Reck, M.
      – PersonEntity:
          Name:
            NameFull: Blasco, A.
      – PersonEntity:
          Name:
            NameFull: Garcia Campelo, R.
      – PersonEntity:
          Name:
            NameFull: Sala González, M.A.
      – PersonEntity:
          Name:
            NameFull: Britschgi, C.
      – PersonEntity:
          Name:
            NameFull: Roschitzki-Voser, H.
      – PersonEntity:
          Name:
            NameFull: Ruepp, B.
      – PersonEntity:
          Name:
            NameFull: Gasca-Ruchti, A.
      – PersonEntity:
          Name:
            NameFull: Haberecker, M.
      – PersonEntity:
          Name:
            NameFull: Dafni, U.
      – PersonEntity:
          Name:
            NameFull: Peters, S.
      – PersonEntity:
          Name:
            NameFull: Stahel, R.A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: April 2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 01695002
          Numbering:
            – Type: volume
              Value: 202
          Titles:
            – TitleFull: Lung Cancer
              Type: main
ResultId 1